BUY Piramal Pharma Limited — Somil Mehta, Sharekhan
bySomil Mehta, SharekhanHorizon: NA (inferred Swing (≤2wk))26 Oct 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·26 Aug · 2mo ago
MACD below its signal line — bearish momentum
Technicals · macd·27 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Piramal Pharma
- BUY — Nirav Chheda, Nirmal Bang Securities24 Sept 2026 · ~1 year · target ₹250 · Active
- BUY — Rakesh Bansal24 Sept 2026 · Same day · target ₹219 · SL hit
- BUY — Goldman Sachs24 Sept 2026 · ~1 year · target ₹250 · Active
- BUY — Siddharth Rai Mangala21 Sept 2026 · ~2 weeks · target ₹230 · SL hit
- BUY — IDBI Capital21 Sept 2026 · ~2 weeks · target ₹219 · SL hit
More from Somil Mehta, Sharekhan
- BUY Sona BLW Precision Forgings26 Oct 2026 · ~2 weeks · target ₹850 · Active
- BUY Union Bank of India26 Oct 2026 · ~3 months · target ₹192 · Active
- BUY Bharti Airtel26 Oct 2026 · Next day · target ₹2,000 · Active
- BUY Eternal26 Oct 2026 · ~2 weeks · target ₹345 · Active
- BUY BSE26 Oct 2026 · ~2 weeks · target ₹3,650 · Active

